Calendar Catalyst Pharmaceuticals, Inc. Deutsche Boerse AG
Stocks
CN2
US14888U1016
Pharmaceuticals
Chart calendar Catalyst Pharmaceuticals, Inc.
Upcoming events on Catalyst Pharmaceuticals, Inc.
No events available
Past events on Catalyst Pharmaceuticals, Inc.
| 2026-07-08 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-07-08 | Extraordinary General Meeting | 09:00 |
| 2026-05-12 | Earnings presentation | 08:30 |
| 2026-05-11 | Earnings release - Q1 2026 | |
| 2026-02-26 | Earnings presentation | 08:30 |
| 2026-02-25 | Earnings release - Q4 2025 | |
| 2025-11-06 | Earnings presentation | 08:30 |
| 2025-11-05 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 398 394 1.18% | 492 484 1.58% | 589 579 1.7% |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 255 211 21.12% | 320 286 12.06% |
|
EBIT Million USD | Released Forecast Spread | 86,8 74,2 17.03% | 195 184 6.33% | 258 250 2.92% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 94,5 84,9 11.38% | 216 198 8.96% | 284 272 4.35% |
|
Net income Million USD | Released Forecast Spread | 71,4 67,0 6.61% | 164 151 8.78% | 214 206 3.99% |
|
EPS USD | Released Forecast Spread | 0,63 0,59 6.33% | 1,31 1,22 7% | 1,68 1,61 4.09% |
| Announcement Date | 28/02/24 | 26/02/25 | 25/02/26 |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 129 123 4.27% | 142 134 5.68% | 141 131 7.85% | 147 140 4.36% | 148 137 8.47% | 153 143 6.91% | 149 148 0.82% |
|
EBITDA Million USD | Released Forecast Spread | 64,8 59,3 9.25% | 77,5 60,1 28.98% | 78,7 56,3 39.73% | 83,4 64,8 28.7% | 81,4 65,3 24.5% | 77,0 70,7 9.04% | 89,3 74,9 19.23% |
|
EBIT Million USD | Released Forecast Spread | 50,9 48,2 5.53% | 62,8 51,2 22.65% | 63,4 54,7 15.82% | 66,3 58,5 13.4% | 66,3 51,4 28.95% | 61,8 54,5 13.41% | 73,2 68,1 7.55% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 57,2 51,2 11.73% | 74,2 56,4 31.51% | 71,3 58,1 22.65% | 69,3 63,2 9.6% | 71,0 55,6 27.87% | 71,9 60,1 19.68% | 84,2 70,1 20.14% |
|
Net income Million USD | Released Forecast Spread | 43,9 38,1 15.16% | 55,9 42,4 32% | 56,7 42,2 34.35% | 52,1 48,6 7.13% | 52,8 41,3 27.85% | 52,7 44,5 18.49% | 63,7 57,2 11.37% |
|
EPS USD | Released Forecast Spread | 0,35 0,30 15.13% | 0,44 0,34 28.87% | 0,45 0,34 32.35% | 0,41 0,39 4.59% | 0,42 0,33 26.51% | 0,41 0,34 19.19% | 0,50 0,46 9.65% |
| Announcement Date | 06/11/24 | 26/02/25 | 07/05/25 | 06/08/25 | 05/11/25 | 25/02/26 | 11/05/26 |
| Today |  | Earnings presentation | 03:30 |
| Today | | Earnings presentation | 03:00 |
| Today | | Earnings presentation | 03:00 |
| Today | | Earnings presentation | 03:00 |
| 2026-09-17 | | Analyst/Investor Day | 21:00 |
| 2026-09-21 | | Ex-dividend date - 0.09 CNY | 00:00 |
| 2026-09-21 | | Earnings presentation | 21:00 |
| 2026-09-21 | | Extraordinary General Meeting | 03:00 |
| 2026-09-21 | | Extraordinary General Meeting | 02:30 |
| 2026-09-23 | | Extraordinary General Meeting | 02:00 |
Past sector events for Catalyst Pharmaceuticals, Inc.
| 2026-09-15 | | Earnings presentation | 03:00 |
| 2026-09-15 | | Earnings presentation | 03:00 |
| 2026-09-15 | | Earnings presentation | 03:00 |
| 2026-09-15 | | Ex-dividend date - 0.12 CNY | 00:00 |
| 2026-09-14 | | Earnings presentation | 22:00 |
| 2026-09-13 | | Earnings presentation | 22:00 |
| 2026-09-12 | | Earnings presentation | |
| 2026-09-10 | | Extraordinary General Meeting | 02:30 |
| 2026-09-10 | | Extraordinary General Meeting | 02:00 |
| 2026-09-09 | | Ex-dividend date - 2.24377 AUD | 00:00 |
